Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial

Currently, there are no medications approved for the treatment of juvenile fibromyalgia (JFM). We evaluated the safety and efficacy of duloxetine 30/60  mg once daily (QD) versus placebo in adolescents with JFM.

Source: Pediatric Rheumatology - May 28, 2019 Category: Rheumatology Authors: Himanshu P. Upadhyaya, Lesley M. Arnold, Karla Alaka, Meihua Qiao, David Williams and Renata Mehta Tags: Research article Source Type: research